tiprankstipranks
Trending News
More News >
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Technical Analysis

Compare
131 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Dermata Therapeutics’s (DRMA) Moving Averages Convergence Divergence (MACD) indicator is -0.29, suggesting Dermata Therapeutics is a Buy.
Dermata Therapeutics’s (DRMA) 20-Day exponential moving average is 2.56, while Dermata Therapeutics’s (DRMA) share price is $2.04, making it a Sell.
Dermata Therapeutics’s (DRMA) 50-Day exponential moving average is 3.18, while Dermata Therapeutics’s (DRMA) share price is $2.04, making it a Sell.

Dermata Therapeutics (DRMA) Pivot Points

Dec 24, 2025, 04:32 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.07
2.10
2.16
2.19
2.25
2.28
2.34
Fibonacci
2.10
2.14
2.16
2.19
2.23
2.25
2.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Dermata Therapeutics (DRMA) Moving Averages

Dec 24, 2025, 04:32 PM
Period
Simple
Exponential
MA5
2.17Sell
2.19Sell
MA10
2.40Sell
2.34Sell
MA20
2.65Sell
2.56Sell
MA50
3.12Sell
3.18Sell
MA100
4.31Sell
4.25Sell
MA200
6.24Sell
6.38Sell
Dermata Therapeutics’s (DRMA) 10-Day exponential moving average is 2.34, while Dermata Therapeutics’s (DRMA) share price is $2.04, making it a Sell.
Dermata Therapeutics’s (DRMA) 100-Day exponential moving average is 4.25, while Dermata Therapeutics’s (DRMA) share price is $2.04, making it a Sell.
Dermata Therapeutics’s (DRMA) stock price is $2.04 and Dermata Therapeutics’s (DRMA) 50-day simple moving average is 3.12, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $2.04 and Dermata Therapeutics’s (DRMA) 100-day simple moving average is 4.31, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $2.04 and Dermata Therapeutics’s (DRMA) 200-day simple moving average is 6.24, creating a Sell signal.

Dermata Therapeutics (DRMA) Technical Indicators

Dec 24, 2025, 04:32 PM
Name
Value
Implied Action
RSI (14)
29.54
Buy
STOCH (9,6)
6.29
Buy
STOCHRSI (14)
5.75
Buy
MACD (12,26)
-0.29
Buy
ADX (14)
38.18
Neutral
Williams %R
-92.61
Buy
CCI (14)
-136.76
Buy
ATR (14)
0.25
-
Ultimate Oscillator
32.64
Neutral
ROC
-32.23
Sell
Dermata Therapeutics’s (DRMA) Relative Strength Index (RSI) is 29.54, creating a Buy signal.
Dermata Therapeutics’s (DRMA) Trend Strength Indicator (ADX) is 38.18, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Commodity Channel Index (CCI) is -136.76, creating a Buy signal.
Dermata Therapeutics’s (DRMA) Price Rate of Change (ROC) is -32.23, creating a Sell signal.

FAQ

Is DRMA a Buy, Hold, or Sell?
Based on DRMA’s technical indicators, DRMA is a Sell.
    What is DRMA’s RSI (14)?
    DRMA’s RSI (14) is 29.54, which suggests DRMA is a Buy.
      What is DRMA’s MACD?
      DRMA’s MACD is -0.29, which suggests DRMA is a Buy.
        What is DRMA’s 5-day moving average?
        DRMA’s 5-day moving average is 2.17, which suggests DRMA is a Sell.
          What is DRMA’s 20-day moving average?
          DRMA 20-day moving average is 2.65, which suggests DRMA is a Sell.
            What is DRMA’s 50-day moving average?
            DRMA’s 50-day moving average is 3.12, which suggests DRMA is a Sell.
              What is DRMA’s 200-day moving average?
              DRMA’s 200-day moving average is 6.24, which suggests DRMA is a Sell.
                What is DRMA’s Williams % R (14)?
                DRMA’s Williams % R (14) is -92.61, which suggests DRMA is a Buy.
                  What is DRMA’s CCI (14)?
                  DRMA’s CCI (14) is -136.76, which suggests DRMA is a Buy.